Effect of serum progesterone on the day of trigger administration to MII oocyte ratio on IVF/ICSI outcomes
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250024Keywords:
IVF/ICSI outcomes, MII oocyte, P-Trigger /MII oocyte ratio, Serum progesterone on trigger dayAbstract
Background: To evaluate the effect of serum progesterone on the day of trigger administration to MII oocyte ratio on IVF/ICSI outcomes. Retrospective observational study in Institute of Reproductive Medicine, The Madras Medical Mission, Chennai.
Methods: 211 patients meeting inclusion and exclusion criteria were subjected to controlled ovarian stimulation with antagonist protocol and were serially monitored by ultrasound and hormonal blood tests and when at least 3 follicles reach 18 mm size, ovulation is triggered with HCG or GnRH agonist. Serum progesterone levels on the day of trigger were noted and oocyte retrieval done 35 hours after trigger injection and the no. of MII oocytes retrieved were noted. Embryo transfer was done on day 3 of oocyte retrieval. Adequate luteal support was given, Pregnancy test was done 16 days after embryo transfer.
Results: On evaluating 211 fresh ICSI–ET cycles, Roc curve was obtained and it showed that when compared with patients with P-trigger/MII oocyte ratio≤0.29 group, patients with P-trigger/MII>0.29 group had a lower clinical pregnancy rate, implantation rate and live birth rate.
Conclusions: The present study reveals that an elevated of P-trigger/MII oocyte ratio is inversely correlated with the probability of pregnancy, indicating that this ratio may be a reliable predictor of IVF outcomes. P/MII ratio could also play a key role in selection of patients for cryopreservation of all embryos (elective freeze-all policy) and subsequent transfer of cryopreserved/thawed embryos.
Metrics
References
Romero W, Rong Z, Yanping M, Deng B, Zhang X, Meng Y, et al. Effect of HCG-day serum progesterone and estradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed. 2012;24:511-20. DOI: https://doi.org/10.1016/j.rbmo.2012.02.003
Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, et al. Elevated progesterone during ovarian stimulation for IVF. Reproductive Biomed. 2012;24:381-8. DOI: https://doi.org/10.1016/j.rbmo.2012.01.010
Bosch E, Labarta E, Crespo J, Simon C, Remohí J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarianstimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25:2092-100. DOI: https://doi.org/10.1093/humrep/deq125
Shulman A, Ghetler Y, Beyth Y, Ben-Nun I. The significance of an early (premature) rise of plasma P in vitro fertilization cycles induced by a “long protocol” of gonadotropin releasing hormone analogue and human meno pausal gonadotropins. J Assist Reprod Genet. 1996;13:207-11. DOI: https://doi.org/10.1007/BF02065937
Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma P alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090-4. DOI: https://doi.org/10.1016/S0015-0282(16)55933-0
Ochsenkühn R, Arzberger A, von Sch€ onfeldt V, Gallwas J, Rogenhofer N, Crispin A, et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril. 2012;98:347-54. DOI: https://doi.org/10.1016/j.fertnstert.2012.04.041
Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril. 1990;54(5):853–7. DOI: https://doi.org/10.1016/S0015-0282(16)53945-4
Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotrophin administration do not predict outcome in assisted reproduction cycles. Fertil Steril. 1994;62(5):1011–7. DOI: https://doi.org/10.1016/S0015-0282(16)57066-6
Ubaldi F, Smitz J, Wisanto A, Joris H, Schiettecatte J, Derde MP, et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod. 1995;10(12):3091–6. DOI: https://doi.org/10.1093/oxfordjournals.humrep.a135864
Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006;21(6):1503–7. DOI: https://doi.org/10.1093/humrep/dei474
Segal S, Glatstein I, McShane P, Hotamisligil S, Ezcurra D, Carson R. Premature luteinization and in vitro fertilization outcome in gonadotropin/ gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome. Fertil Steril. 2009;91(5):1755–9. DOI: https://doi.org/10.1016/j.fertnstert.2008.02.009
Lai TH, Lee FK, Lin TK, Horng SG, Chen SC, Chen YH, et al. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negativeimpact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol. Fertil Steril. 2009;92:508–14. DOI: https://doi.org/10.1016/j.fertnstert.2008.06.036
Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. J Assist Reprod Genet. 2010;27(4):149–55. DOI: https://doi.org/10.1007/s10815-010-9393-8
Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19(5):433–57. DOI: https://doi.org/10.1093/humupd/dmt014
Al-Azemi M, Kyrou D, Papanikolaou EG, Polyzos NP, Devroey P, Fatemi HM. The relationship between premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/rec-FSH stimulated cycles. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):165–8. DOI: https://doi.org/10.1016/j.ejogrb.2012.02.025
Ezra Y, Simon A, Sherman Y, Benschushan A, Younis JS, Laufer N. The effect of progesterone administration in the follicular phase of an artificial cycle on endometrial morphology: a model of premature luteinization. Fertil Steril. 1994;62(1):108–12. DOI: https://doi.org/10.1016/S0015-0282(16)56824-1
Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515–22. DOI: https://doi.org/10.1093/humupd/dmg045
Yovel I, Yaron Y, Amit A, Peyser MR, David MP, Kogosowski A, et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in-vitro fertilization and oocyte donation programs. Fertil Steril. 1995;64(1): 128–31. DOI: https://doi.org/10.1016/S0015-0282(16)57668-7
Shufaro Y, Sapir O, Oron G, Ben Haroush A, Garor R, Pinkas H, et al. Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level. Fertil Steril. 2015;103(3):669–74. DOI: https://doi.org/10.1016/j.fertnstert.2014.11.026
Roque M, Valle M, Sampaio M, Geber S, Checa MA. Ratio of progesterone-to-number of follicles as a prognostic tool for in vitro fertilization cycles. J Assist Reprod Genet. 2015;32(6):951–7. DOI: https://doi.org/10.1007/s10815-015-0487-1
Mahran A, Khairy M, Elkhateeb R, Hegazy AR, Abdelmeged A, Batiha GE, et al. The value of serum progesterone level on day of human chorionic gonadotrophin administration/metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve. J Ovar Res. 2022;14:1-10. DOI: https://doi.org/10.1186/s13048-021-00800-5
Badr I, Sayed H, Mohammed Y, Mohamed A, Shehata M. Correlation between Elevated Serum Progesterone in the Day of Hcg Injection, Metaphase II Oocytes and Their Impact on The Success of ICSI. Indian J of Forensic Medicine & Toxic. 2021;15(1):258-9.
Singh N, Malik N, Malhotra N, Vanamail P, Gupta M. Impact of progesterone (on hCG day)/oocyte ratio on pregnancy outcome in long agonist non donor fresh IVF/ICSI cycles. Taiwanese J of Obstetri Gynecol. 2016;55(4):503-6. DOI: https://doi.org/10.1016/j.tjog.2015.09.005
Huang LJ, Wan Q, Li T, Lv XY, Geng LH, He QQ, Zhong ZH, Li Y, Tang XJ. Effect of serum progesterone on human chorionic gonadotropin trigger day/metaphase II oocyte ratio on pregnancy and neonatal outcomes in women undergoing ICSI cycle. BMC Pregnancy and Childbirth. 2023;23(1):224. DOI: https://doi.org/10.1186/s12884-023-05549-x
Li R, Qiao J, Wang L, Li L, Zhen X, Liu P, et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol. 2011;9:29. DOI: https://doi.org/10.1186/1477-7827-9-29
Aflatoonian A, Davar R, Hojjat F. Elevated serum progesterone/ MII oocyte ratio on the day of human chorionic gonadotropin administration can predict impaired endometrial receptivity. Iran J Reprod Med. 2014;12(6):427-34.
Burns WN, Witz CA, Klein NA, Silverberg KM, Schenken RS. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in-vitro fertilization/ embryo transfer outcome. J Assist Reprod Genet 1994;11:17-23. DOI: https://doi.org/10.1007/BF02213692
Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, et al. Serum P concentrations on the day of hCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online. 2004;8:183-90. DOI: https://doi.org/10.1016/S1472-6483(10)60514-7
Xu, Z Li, H Zhang, L Jin, Y Li, J Ai, G Zhu, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertility and Steril. 2012;2:345-8. DOI: https://doi.org/10.1016/j.fertnstert.2012.03.014
Downloads
Published
How to Cite
Issue
Section
